| First Author | Liu S | Year | 2012 |
| Journal | Biochem Biophys Res Commun | Volume | 420 |
| Issue | 1 | Pages | 78-83 |
| PubMed ID | 22406061 | Mgi Jnum | J:182580 |
| Mgi Id | MGI:5316138 | Doi | 10.1016/j.bbrc.2012.02.118 |
| Citation | Liu S, et al. (2012) A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells. Biochem Biophys Res Commun 420(1):78-83 |
| abstractText | CYLD, a deubiquitinating enzyme (DUB), is a critical regulator of diverse cellular processes, ranging from proliferation and differentiation to inflammatory responses, via regulating multiple key signaling cascades such as nuclear factor kappa B (NF-kappaB) pathway. CYLD has been shown to inhibit vascular lesion formation presumably through suppressing NF-kappaB activity in vascular cells. However, herein we report a novel role of CYLD in mediating pro-inflammatory responses in vascular smooth muscle cells (VSMCs) via a mechanism independent of NF-kappaB activity. Adenoviral knockdown of Cyld inhibited basal and the tumor necrosis factor alpha (TNFalpha)-induced mRNA expression of pro-inflammatory cytokines including monocyte chemotactic protein-1 (Mcp-1), intercellular adhesion molecule (Icam-1) and interleukin-6 (Il-6) in rat adult aortic SMCs (RASMCs). The CYLD deficiency led to increases in the basal NF-kappaB transcriptional activity in RASMCs; however, did not affect the TNFalpha-induced NF-kappaB activity. Intriguingly, the TNFalpha-induced IkappaB phosphorylation was enhanced in the CYLD deficient RASMCs. While knocking down of Cyld decreased slightly the basal expression levels of IkappaBalpha and IkappaBbeta proteins, it did not alter the kinetics of TNFalpha-induced IkappaB protein degradation in RASMCs. These results indicate that CYLD suppresses the basal NF-kappaB activity and TNFalpha-induced IkappaB kinase activation without affecting TNFalpha-induced NF-kappaB activity in VSMCs. In addition, knocking down of Cyld suppressed TNFalpha-induced activation of mitogen activated protein kinases (MAPKs) including extracellular signal-activated kinases (ERK), c-Jun N-terminal kinase (JNK), and p38 in RASMCs. TNFalpha-induced RASMC migration and monocyte adhesion to RASMCs were inhibited by the Cyld knockdown. Finally, immunochemical staining revealed a dramatic augment of CYLD expression in the injured coronary artery with neointimal hyperplasia. Taken together, our results uncover an unexpected role of CYLD in promoting inflammatory responses in VSMCs via a mechanism involving MAPK activation but independent of NF-kappaB activity, contributing to the pathogenesis of vascular disease. |
